The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) for the Detection of Dysplasia in Barrett's Esophagus and in Post Ablation Barrett's Esophagus

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01084629

Enrollment

Registered

2010-03-10

Start date

2010-11-30

Completion date

2016-11-04

Last updated

2021-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's Esophagus

Keywords

Barrett's Esophagus, Surveillance

Brief summary

The purpose of this study to assess post ablation, if there are areas of Barrett's mucosa post ablation and to assess the ability of the Fujinon FICE system to detect this, as compared to white light endoscopy. A subgroup will also be compared with laser confocal microscopy

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Visible Barrett's esophagus * Scheduled for Surveillance Endoscopy * Able to undergo endoscopy

Exclusion criteria

* Unable to undergo endoscopy * Unable to stop blood thinning medications

Design outcomes

Primary

Measure	Time frame	Description
detection of dysplasic areas	during surveillance endoscopy	Areas of residual mucosa will be scored for being present, absent or suspicious. The ability of both FICE and white light endoscopy to find areas will be graded on the number of areas found, and the size of the areas estimated at the time of endoscopy

Countries

United States

Outcome results